Corcept Therapeutics (CORT) revenue

Revenue · fiscal 2025
$761.41M

Corcept Therapeutics (CORT) reported revenue of $761.41M in fiscal 2025 (the year ended December 31, 2025). That is 12.8% higher than the $675.04M of fiscal 2024. Figures as of 18 Nov 2026, 06:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$761.41M
Change on fiscal 2024
+12.8%
Growth, 5 years
+16.6% a year
Growth, 10 years
+31.2% a year
Highest on record
$761.41Mfiscal 2025
Lowest on record
$29.00Kfiscal 2009
Fiscal years on record
152009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corcept Therapeutics revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 16.6% a year; over ten years the rate was 31.2% a year. Across the 15 fiscal years on record (2009–2025), the highest was $761.41M in fiscal 2025 and the lowest $29.00K in fiscal 2009.

History · 15 fiscal years

Revenue by fiscal year

Corcept Therapeutics revenue, year by year

Corcept Therapeutics (CORT) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$761.41M 12.8% up
2024$675.04M 39.9% up
2023$482.38M 20.0% up
2022$401.86M 9.8% up
2021$365.98M 3.4% up
2020$353.87M 15.5% up
2019$306.49M 22.0% up
2018$251.25M 57.8% up
2017$159.20M 95.8% up
2016$81.32M 61.7% up
2015$50.29M 89.4% up
2014$26.55M 156.4% up
2013$10.36M 213.2% up
2012$3.31M—
2009$29.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Corcept Therapeutics and comparable companies
CompanyRevenueFiscal year
10x Genomics TXG$642.82M2025
HealthEquity HQY$1.31B2026
Corcept Therapeutics CORT$761.41M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics revenue: questions and answers

What is Corcept Therapeutics's revenue?

Corcept Therapeutics (CORT) reported revenue of $761.41M in fiscal 2025 (the year ended December 31, 2025). That is 12.8% higher than the $675.04M of fiscal 2024.

What is the growth rate of Corcept Therapeutics's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 16.6% a year; over ten years the rate was 31.2% a year.

What are the highest and lowest revenue figures on record for Corcept Therapeutics?

Across the 15 fiscal years on record (2009–2025), the highest was $761.41M in fiscal 2025 and the lowest $29.00K in fiscal 2009.

How is Corcept Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/CORT/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.